FDA Drug Recalls

Recalls / Class II

Class IID-1173-2016

Product

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY

Affected lot / code info
Lot #: 151220-4, BUD: 06/17/16; Lot #: 160216-31, BUD: 08/14/16

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Medaus, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6801 Cahaba Valley Rd Ste 116, Birmingham, Alabama 35242-9609

Distribution

Quantity
4000 mL in Vials
Distribution pattern
U.S. Nationwide, Japan, and New Zealand.

Timeline

Recall initiated
2016-05-13
FDA classified
2016-07-08
Posted by FDA
2016-07-20
Terminated
2017-06-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1173-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.